MarkAlanMatsonMD

Clinical Trials

• A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Start of enrollment: 2010 Sep 01

  Completed

  Phase 1

• Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus Start of enrollment: 2010 Nov 01

  Completed

  Phase 1, Phase 2

• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension Start of enrollment: 2012 Jan 01

  Completed

  Phase 1

• Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers Start of enrollment: 2013 Jul 01

  Unknown status

  Phase 1

• Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects Start of enrollment: 2013 Apr 01

  Completed

  Phase 2, Phase 3

• A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers Start of enrollment: 2014 Mar 01

  Completed

  Phase 1

• A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers Start of enrollment: 2014 May 01

  Completed

  Phase 1

• A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products Start of enrollment: 2015 Sep 01

  Completed

  Not Applicable

• Implant Pharmacokinetic and Pharmacodynamic Study Start of enrollment: 2009 Sep 01

  Completed

  Phase 1

• Join now to see all